Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

2 Obvious Reasons I Like Blackmores (BKL) Shares In 2019

Blackmores Limited (ASX: BKL) shares have had a bad year so far, down 42.5% since January. Here are two reasons I think the shares are still worth watching.

The Blackmores Limited (ASX: BKL) share price has had a bad year so far, down 42.5% since January. Yikes!

Who is Blackmores?

Blackmores describes itself as Australia’s leading natural health company. Maurice Blackmore founded the company in the 1930s. Blackmores has a number of different brands, not just the well-recognised Blackmores brand. It operates BioCeuticals, the Blackmores Institute, Fusion Health & Oriental Botanicals, Impromy, IsoWhey and Pure Animal Wellbeing (PAW).

Here are two reasons I think the shares are still worth watching…

1. The Products

The first reason I like Blackmores shares is because of the products they sell. Blackmores, through its extensive vitamins range, has established itself as the leading player in multiple markets, giving the company a distinct competitive advantage.

In the FY19 annual report, Blackmores reported that it is the number-one vitamin brand in Australia, Thailand, Singapore and Malaysia. When most Australians think of vitamins, Blackmores is the first company to come to mind and that’s powerful in terms of pricing and loyalty.

Sustainable competitive advantages are reflected in a company’s return on equity (ROE) and return on capital (ROC). Blackmores has for some time consistently had an ROE above 25%, suggesting the competitive advantage is alive and well.

Blackmores looks set to maintain this competitive advantage, with 142 new products released during FY19.

2. Growth Prospects In Asia

Much of the reason for the declining share price has been regulatory changes in China that impacted sales in FY19, with total China revenue down 15% to $122 million. However, in-country sales increased 22% and Blackmores still looks set to take advantage of Chinese growth over the longer term.

Also, as much as some analysts would have you believe, China is not the only country in Asia. In fact, Blackmores saw sales from other Asian countries increase by 30% in FY19 to reach $107 million, which is not far off total revenue from China.

As the leading vitamins brand in three Asian countries, I believe Blackmores will continue to see strong growth in Asia, even if Chinese sales have been impacted by regulatory changes.

Buy, Hold Or Sell

I’m not sure yet if Blackmores is a buy at its current price, but with shares 42.5% cheaper than in January and the outlook still reasonably positive, it’s certainly worth a closer look.

For other shares with big growth opportunities, have a look at the free report below.

[ls_content_block id=”14947″ para=”paragraphs”]

Disclosure: At the time of writing, Max does not own shares in any of the companies mentioned.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content